North Korea to receive nearly 2 million AstraZeneca vaccine doses in first half -interim report

FILE PHOTO: A vial of the Oxford University/AstraZeneca COVID-19 vaccine is seen at the Lochee Health Centre in Dundee, Scotland, Britain January 4, 2021. Andy Buchanan/Pool via REUTERS/File Photo

(Reuters) - North Korea is expected to receive nearly two million doses of the AstraZeneca-Oxford COVID-19 vaccine by the first half of this year, said agencies leading the COVAX vaccine-sharing programme.

The COVAX Facility will distribute 1.992 million doses of the vaccine produced by the Serum Institute of India, according to the COVAX interim distribution report on Wednesday.

COVAX, which secures vaccines for poor countries, is co-led by the GAVI alliance, the World Health Organization (WHO), the Coalition for Epidemic Preparedness Innovations and the U.N. Children’s Fund.

North Korea has not reported a single case of COVID-19 till date, according to the WHO website.

Reporting by Anirudh Saligrama and Rama Venkat in Bengaluru; Editing by Kim Coghill and Tom Hogue